Back to database

Deal Detail

GNC Holdings Inc to Harbin Pharmaceutical Group

EV / LTM EBITDA
6.9x
EV / LTM Sales
-
Enterprise Value
$780M
Primary Source
UBS

All Observations

Source-specific multiples and notes for this transaction.

Primary?Source TypeFairness Opinion / SourceAdvisorSource YearEnterprise ValueEV/SalesEV/EBITDAEV/Fwd EBITDANoteCitation
Primaryfairness opinionMIK FOUBS2021$780M-6.9x--Open
-fairness opinionFRG FOJefferies2023--6.9x--Open
-fairness opinionFRG FOJefferies2023--6.9x-HardlinesOpen